Document is current
Any future updates will be listed below
-
Authors
Taflin, Helena
Odin, Elisabeth
Carlsson, Göran
Gustavsson, Bengt
Hemmingsson, Oskar
Wettergren, Yvonne
Urbanowicz, Krzysztof
Turyn, Jacek
Smolenski, Ryszard T.
Peters, Godefridus J.
-
Funding
Funding for this research was provided by:
Swedish Cancer Society (CAN 2015/499, CAN 2018, CAN 201025)
Swedish Cancer Society (CAN 2015/499, CAN 2018, CAN 201025)
Swedish Cancer Society (CAN 2015/499, CAN 2018, CAN 201025)
Swedish Cancer Society (CAN 2015/499, CAN 2018, CAN 201025)
the Swedish state under the LUA/ALF agreement (ALFGBG-426941, ALFGBG-586631, ALFGBG-723361, ALFGBG-788901, ALFGBG-966007)
the Swedish state under the LUA/ALF agreement (ALFGBG-426941, ALFGBG-586631, ALFGBG-723361, ALFGBG-788901, ALFGBG-966007)
the Swedish state under the LUA/ALF agreement (ALFGBG-426941, ALFGBG-586631, ALFGBG-723361, ALFGBG-788901, ALFGBG-966007)
the Swedish state under the LUA/ALF agreement (ALFGBG-426941, ALFGBG-586631, ALFGBG-723361, ALFGBG-788901, ALFGBG-966007)
Swedish Society of Medicine
The Gothenburg Society of Medicine
IngaBritt and Arne Lundberg Foundation (335/07)
IngaBritt and Arne Lundberg Foundation (335/07)
IngaBritt and Arne Lundberg Foundation (335/07)
IngaBritt and Arne Lundberg Foundation (335/07)
Isofol Medical AB (unconditional grant)
- License Information
-
More Information
Article History
Received: 24 May 2024
Revised: 18 October 2024
Accepted: 20 October 2024
First Online: 20 November 2024
Competing interests
: The authors declare the following financial interests/personal relationships, which may be considered as potential competing interests: E. Odin, G. Carlsson, B. Gustavsson, and Y. Wettergren are registered inventors of patents held by Isofol Medical AB. Y. Wettergren, G. Carlsson and G. Peters have previously received honoraria for advisory board role. B Gustavsson is the founder of Isofol, and E. Odin and B. Gustavsson are shareholders. HT is a member of the Isofol Board.
: The study was conducted according to the guidelines set forth in the Declaration of Helsinki and was approved by the Swedish Ethical Review Authority (2019-00962). Written informed consent was obtained from all included participants.
